Page 69 - Zai Lab News Today

Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028

Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028

/PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner....

/PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner....

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

FreightWeek - Insights on sustainable business practices for the global logistics industry

China’s pharmaceutical sector, long known for generic drugs and raw materials, is rapidly emerging as a force in innovative medicines. This dovetails with Beijing’s ambition to surpass the U.S. industry, especially in biologics. China’s methods, however, have drawn significant criticism.

Muscat- SOHAR Port and Freezone signed a Memorandum of Understanding (MOU) with the University of Technology and Applied Sciences (UTAS) in Suhar which will see the development of an AI Lab on campus. Signed by HE. Dr. Saeed bin Hamad al Rubaie, Vice-Chancellor of the University Technology and Applied Sciences and Omar bin Hamood Al Mahrizi, Deputy CEO SOHAR...

MUSCAT: SOHAR Port and Freezone signed a Memorandum of Understanding (MOU) with the University of Technology and Applied Sciences (UTAS) in Suhar which will see the development of an AI Lab on campus. Signed by Dr Said bin Hamad al Rubaie, Vice Chancellor of the University Technology and Applied Sciences and Omar bin Hamood al Mahrizi, Deputy CEO SOHAR Port...